Clinical Nutrition Market Size By Product [Infant Nutrition (Milk, Soy, Organic), Parenteral Nutrition (Amino Acids, Fats, Carbohydrates), Enteral Nutrition (Standard Composition, Disease Specific Composition)], By Consumer (Child, Adult),By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, The Benelux Union, Rest of Europe, China, Japan, India, Australia, New Zealand, South Korea Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027’
Industry Trends
Global clinical nutrition market was valued at US$ 51,150.0 million in 2018 and is estimated to reach US$ 98,520.0 million by 2027, growing at a CAGR of 7.6% from 2019 to 2027.
Global Clinical Nutrition Market Revenue, 2019 - 2027
Rising incidences of chronic diseases such as diabetes, respiratory disorders, cancer amongst others, expanding geriatric population base and rising birth rate are some of the major factors driving global clinical nutrition market growth. The need to provide continuous nutrition to patients suffering from chronic diseases will spur demand for nutritional products during the forecast timeframe.
Eating and digestive problems faced by elderly population that require external supply of vital nutrients through enteral or parenteral medium is another major driving factor to market growth. Moreover, the need to address malnourishment in pre-mature babies, children and adults largely contributes to the rising demand for various nutritional products. According to latest statistics by WHO 2017, nearly 15 million pre-mature or pre-term birth happen every year globally, of which a significantly large proportion require external nutrition. Not only pre-term babies but the ones with normal birth term also require some or other form of nutrition; therefore, rapidly rising birth rate in emerging countries such as India and China will strongly drive the infant nutrition market growth over the next eight years.
However, stringent regulation related to clinical nutrition product approval and administration proves to be a major hurdle in market expansion path. Moreover, lack of awareness regarding various clinical nutrition solutions and availability of the same hinder their adoption and thus market growth, especially in resource poor nations.
Parenteral, enteral and infant nutrition are major categories under clinical nutrition. Infant nutrition market segment held the largest market share in 2018 and it is estimated to expand at a CAGR of over 9% during the projection period. Infant nutrition market growth is attributed to the rising rate of pre-mature and pre-term births, to births in general, and to timely introduction of new infant products and spreading trend of adoption of infant nutrition across the globe.
In 2018, children clinical nutrition market held largest share in the clinical nutrition industry. Rising disposable income of parents coupled with growing number of working mothers are major demand driving factors. Moreover, rising preference of infant nutrition products over traditional alternatives in developing and under developed economies is augmenting demand.
North America clinical nutrition market dominated the global industry in 2018, and within the region, U.S. clinical nutrition market held the largest share. Rise in chronic disease due to sedentary lifestyle and unhealthy eating habits result in high demand for various nutritional products across the U.S.
In 2018, China clinical nutrition market held largest value in Asia Pacific clinical nutrition market and is estimated to grow with highest CAGR over the forecast period. Improving healthcare system, rising per capita healthcare spending and growing acceptance of infant nutrition will drive the market. Moreover, many companies aim to explore and exploit Chinese market, which will ultimately result in market expansion.
The report provides both, qualitative and quantitative research of global clinical nutrition market, it also provides penetrative insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in the market and detailed insights into the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes its headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
Competitive Landscape
Major industry participants in global clinical nutrition market are Fresenius Kabi, Abbott Laboratories, B.Braun, Baxter, Danone, Mead Johnson, Nestle and Perrigo among others. New product launches, merger and acquisition and geographical expansion are some of the major strategies adopted by these players to gain a competitive edge.
Global Clinical Nutrition Market:
- By Product
- Infant nutrition
- Milk formulas
- Soy formulas
- Organic formulas
- Others
- Enteral Nutrition
- Standard composition
- Disease specific composition
- Parenteral nutrition
- Amino acids
- Fats
- Carbohydrates
- Others
- By Consumer
- Children
- Adult
- By Geography
- North America
- S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Norway
- Sweden
- Benelux Union
- Belgium
- The Netherlands
- Luxemburg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia)
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East and Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
- Infant nutrition
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2017
1.2.2. Base Year: 2018
1.2.3. Forecast Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Clinical Nutrition Market
6. Market Synopsis:
Clinical Nutrition Market
7. Clinical Nutrition Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Clinical Nutrition Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Clinical
Nutrition Market
7.6. Industry Gross Margin Overview
7.7. Porter’s Five Force Analysis
8. Global Clinical Nutrition Market Analysis and Forecasts, 2019
– 2027
8.1. Overview
8.1.1. Global Clinical Nutrition Market Revenue (US$ Mn)
8.2. Global Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
8.2.1. Infant Nutrition
(Definition, Market Penetration (2018), Market Estimation (2015 – 2018),
Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Milk formulas , Soy formulas , Organic formulas ,
Others )
8.2.1.1. Milk formulas
8.2.1.2. Soy formulas
8.2.1.3. Organic formulas
8.2.1.4. Others
8.2.2. Enteral Nutrition
(Definition, Market Penetration (2018), Market Estimation (2015 – 2018),
Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Standard composition , Disease specific composition
)
8.2.2.1. Standard composition
8.2.2.2. Disease specific composition
8.2.3. Parenteral Nutrition (Definition, Market Penetration (2018),
Market Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on Amino acids , Fats,
Carbohydrates , Others )
8.2.3.1. Amino acids
8.2.3.2. Fats
8.2.3.3. Carbohydrates
8.2.3.4. Others
8.3. Key Segment for Channeling Investments
8.3.1. By Product
9. Global Clinical Nutrition Market Analysis and Forecasts, 2019
– 2027
9.1. Overview
9.2. Global Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
9.2.1. Children
9.2.1.1. Definition
9.2.1.2. Market Penetration, 2018
9.2.1.3. Market Estimation, 2015 – 2018
9.2.1.4. Market Forecast, 2019 – 2027
9.2.1.5. Compound Annual Growth Rate (CAGR)
9.2.1.6. Regional Bifurcation
9.2.1.6.1. North America
9.2.1.6.1.1. Market
Estimation, 2015 – 2018
9.2.1.6.1.2. Market
Forecast, 2019 – 2027
9.2.1.6.2. Europe
9.2.1.6.2.1. Market
Estimation, 2015 – 2018
9.2.1.6.2.2. Market
Forecast, 2019 – 2027
9.2.1.6.3. Asia Pacific
9.2.1.6.3.1. Market
Estimation, 2015 – 2018
9.2.1.6.3.2. Market
Forecast, 2019 – 2027
9.2.1.6.4. Middle East and Africa
9.2.1.6.4.1. Market
Estimation, 2015 – 2018
9.2.1.6.4.2. Market
Forecast, 2019 – 2027
9.2.1.6.5. Latin America
9.2.1.6.5.1. Market
Estimation, 2015 – 2018
9.2.1.6.5.2. Market
Forecast, 2019 – 2027
9.2.2. Adult
9.2.2.1. Definition
9.2.2.2. Market Penetration, 2018
9.2.2.3. Market Estimation, 2015 – 2018
9.2.2.4. Market Forecast, 2019 – 2027
9.2.2.5. Compound Annual Growth Rate (CAGR)
9.2.2.6. Regional Bifurcation
9.2.2.6.1. North America
9.2.2.6.1.1. Market
Estimation, 2015 – 2018
9.2.2.6.1.2. Market
Forecast, 2019 – 2027
9.2.2.6.2. Europe
9.2.2.6.2.1. Market
Estimation, 2015 – 2018
9.2.2.6.2.2. Market
Forecast, 2019 – 2027
9.2.2.6.3. Asia Pacific
9.2.2.6.3.1. Market
Estimation, 2015 – 2018
9.2.2.6.3.2. Market
Forecast, 2019 – 2027
9.2.2.6.4. Middle East and Africa
9.2.2.6.4.1. Market
Estimation, 2015 – 2018
9.2.2.6.4.2. Market
Forecast, 2019 – 2027
9.2.2.6.5. Latin America
9.2.2.6.5.1. Market
Estimation, 2015 – 2018
9.2.2.6.5.2. Market
Forecast, 2019 – 2027
9.3. Key Segment for Channeling Investments
9.3.1. By Consumer
10. North America Clinical Nutrition Market Analysis and
Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North America Clinical Nutrition Market Revenue (US$ Mn)
10.2. North America Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
10.2.1. Infant Nutrition
10.2.1.1. Milk formulas
10.2.1.2. Soy formulas
10.2.1.3. Organic formulas
10.2.1.4. Others
10.2.2. Enteral Nutrition
10.2.2.1. Standard composition
10.2.2.2. Disease specific composition
10.2.3. Parenteral nutrition
10.2.3.1. Amino acids
10.2.3.2. Fats
10.2.3.3. Carbohydrates
10.2.3.4. Others
10.3. North America Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
10.3.1. Children
10.3.2. Adult
10.4. North America Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S Clinical Nutrition Market Revenue (US$ Mn) and Forecasts,
By Product
10.4.1.1.1. Infant Nutrition
10.4.1.1.1.1. Milk
formulas
10.4.1.1.1.2. Soy
formulas
10.4.1.1.1.3. Organic
formulas
10.4.1.1.1.4. Others
10.4.1.1.2. Enteral Nutrition
10.4.1.1.2.1. Standard
composition
10.4.1.1.2.2. Disease
specific composition
10.4.1.1.3. Parenteral nutrition
10.4.1.1.3.1. Amino
acids
10.4.1.1.3.2. Fats
10.4.1.1.3.3. Carbohydrates
10.4.1.1.3.4. Others
10.4.1.2. U.S Clinical Nutrition Market Revenue (US$ Mn) and Forecasts,
By Consumer
10.4.1.2.1. Children
10.4.1.2.2. Adult
10.4.2. Canada
10.4.2.1. Canada Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
10.4.2.1.1. Infant Nutrition
10.4.2.1.1.1. Milk
formulas
10.4.2.1.1.2. Soy
formulas
10.4.2.1.1.3. Organic
formulas
10.4.2.1.1.4. Others
10.4.2.1.2. Enteral Nutrition
10.4.2.1.2.1. Standard
composition
10.4.2.1.2.2. Disease
specific composition
10.4.2.1.3. Parenteral nutrition
10.4.2.1.3.1. Amino
acids
10.4.2.1.3.2. Fats
10.4.2.1.3.3. Carbohydrates
10.4.2.1.3.4. Others
10.4.2.2. Canada Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
10.4.2.2.1. Children
10.4.2.2.2. Adult
10.4.3. Mexico
10.4.3.1. Mexico Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
10.4.3.1.1. Infant Nutrition
10.4.3.1.1.1. Milk
formulas
10.4.3.1.1.2. Soy
formulas
10.4.3.1.1.3. Organic
formulas
10.4.3.1.1.4. Others
10.4.3.1.2. Enteral Nutrition
10.4.3.1.2.1. Standard
composition
10.4.3.1.2.2. Disease
specific composition
10.4.3.1.3. Parenteral nutrition
10.4.3.1.3.1. Amino
acids
10.4.3.1.3.2. Fats
10.4.3.1.3.3. Carbohydrates
10.4.3.1.3.4. Others
10.4.3.2. Mexico Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
10.4.3.2.1. Children
10.4.3.2.2. Adult
10.4.4. Rest of North America
10.4.4.1. Rest of North America Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Product
10.4.4.1.1. Infant Nutrition
10.4.4.1.1.1. Milk
formulas
10.4.4.1.1.2. Soy
formulas
10.4.4.1.1.3. Organic
formulas
10.4.4.1.1.4. Others
10.4.4.1.2. Enteral Nutrition
10.4.4.1.2.1. Standard
composition
10.4.4.1.2.2. Disease
specific composition
10.4.4.1.3. Parenteral nutrition
10.4.4.1.3.1. Amino
acids
10.4.4.1.3.2. Fats
10.4.4.1.3.3. Carbohydrates
10.4.4.1.3.4. Others
10.4.4.2. Rest of North America Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Consumer
10.4.4.2.1. Children
10.4.4.2.2. Adult
10.5. Key Segment for Channeling Investments
10.5.1. By Country
10.5.2. By Product
10.5.3. By Consumer
11. Europe Clinical Nutrition Market Analysis and Forecasts, 2019
- 2027
11.1. Overview
11.1.1. Europe Clinical Nutrition Market Revenue (US$ Mn)
11.2. Europe Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.2.1. Infant Nutrition
11.2.1.1. Milk formulas
11.2.1.2. Soy formulas
11.2.1.3. Organic formulas
11.2.1.4. Others
11.2.2. Enteral Nutrition
11.2.2.1. Standard composition
11.2.2.2. Disease specific composition
11.2.3. Parenteral nutrition
11.2.3.1. Amino acids
11.2.3.2. Fats
11.2.3.3. Carbohydrates
11.2.3.4. Others
11.3. Europe Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.3.1. Children
11.3.2. Adult
11.4. Europe Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.1. France
11.4.1.1. France Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.4.1.1.1. Infant Nutrition
11.4.1.1.1.1. Milk
formulas
11.4.1.1.1.2. Soy
formulas
11.4.1.1.1.3. Organic
formulas
11.4.1.1.1.4. Others
11.4.1.1.2. Enteral Nutrition
11.4.1.1.2.1. Standard
composition
11.4.1.1.2.2. Disease
specific composition
11.4.1.1.3. Parenteral nutrition
11.4.1.1.3.1. Amino
acids
11.4.1.1.3.2. Fats
11.4.1.1.3.3. Carbohydrates
11.4.1.1.3.4. Others
11.4.1.2. France Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.4.1.2.1. Children
11.4.1.2.2. Adult
11.4.2. The UK
11.4.2.1. The UK Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.4.2.1.1. Infant Nutrition
11.4.2.1.1.1. Milk
formulas
11.4.2.1.1.2. Soy
formulas
11.4.2.1.1.3. Organic
formulas
11.4.2.1.1.4. Others
11.4.2.1.2. Enteral Nutrition
11.4.2.1.2.1. Standard
composition
11.4.2.1.2.2. Disease
specific composition
11.4.2.1.3. Parenteral nutrition
11.4.2.1.3.1. Amino
acids
11.4.2.1.3.2. Fats
11.4.2.1.3.3. Carbohydrates
11.4.2.1.3.4. Others
11.4.2.2. The UK Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.4.2.2.1. Children
11.4.2.2.2. Adult
11.4.3. Spain
11.4.3.1. Spain Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.4.3.1.1. Infant Nutrition
11.4.3.1.1.1. Milk
formulas
11.4.3.1.1.2. Soy
formulas
11.4.3.1.1.3. Organic
formulas
11.4.3.1.1.4. Others
11.4.3.1.2. Enteral Nutrition
11.4.3.1.2.1. Standard
composition
11.4.3.1.2.2. Disease
specific composition
11.4.3.1.3. Parenteral nutrition
11.4.3.1.3.1. Amino
acids
11.4.3.1.3.2. Fats
11.4.3.1.3.3. Carbohydrates
11.4.3.1.3.4. Others
11.4.3.2. Spain Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.4.3.2.1. Children
11.4.3.2.2. Adult
11.4.4. Germany
11.4.4.1. Germany Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.4.4.1.1. Infant Nutrition
11.4.4.1.1.1. Milk
formulas
11.4.4.1.1.2. Soy
formulas
11.4.4.1.1.3. Organic
formulas
11.4.4.1.1.4. Others
11.4.4.1.2. Enteral Nutrition
11.4.4.1.2.1. Standard
composition
11.4.4.1.2.2. Disease
specific composition
11.4.4.1.3. Parenteral nutrition
11.4.4.1.3.1. Amino
acids
11.4.4.1.3.2. Fats
11.4.4.1.3.3. Carbohydrates
11.4.4.1.3.4. Others
11.4.4.2. Germany Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.4.4.2.1. Children
11.4.4.2.2. Adult
11.4.5. Italy
11.4.5.1. Italy Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.4.5.1.1. Infant Nutrition
11.4.5.1.1.1. Milk
formulas
11.4.5.1.1.2. Soy
formulas
11.4.5.1.1.3. Organic
formulas
11.4.5.1.1.4. Others
11.4.5.1.2. Enteral Nutrition
11.4.5.1.2.1. Standard
composition
11.4.5.1.2.2. Disease
specific composition
11.4.5.1.3. Parenteral nutrition
11.4.5.1.3.1. Amino
acids
11.4.5.1.3.2. Fats
11.4.5.1.3.3. Carbohydrates
11.4.5.1.3.4. Others
11.4.5.2. Italy Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.4.5.2.1. Children
11.4.5.2.2. Adult
11.4.6. Nordic Countries
11.4.6.1. Nordic Countries Clinical Nutrition Market Revenue (US$ Mn)
and Forecasts, By Product
11.4.6.1.1. Infant Nutrition
11.4.6.1.1.1. Milk
formulas
11.4.6.1.1.2. Soy
formulas
11.4.6.1.1.3. Organic
formulas
11.4.6.1.1.4. Others
11.4.6.1.2. Enteral Nutrition
11.4.6.1.2.1. Standard
composition
11.4.6.1.2.2. Disease
specific composition
11.4.6.1.3. Parenteral nutrition
11.4.6.1.3.1. Amino
acids
11.4.6.1.3.2. Fats
11.4.6.1.3.3. Carbohydrates
11.4.6.1.3.4. Others
11.4.6.2. Nordic Countries Clinical Nutrition Market Revenue (US$ Mn)
and Forecasts, By Consumer
11.4.6.2.1. Children
11.4.6.2.2. Adult
11.4.6.3. Nordic Countries Clinical Nutrition Market Revenue (US$ Mn)
and Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux Union
11.4.7.1. Benelux Union Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.4.7.1.1. Infant Nutrition
11.4.7.1.1.1. Milk
formulas
11.4.7.1.1.2. Soy
formulas
11.4.7.1.1.3. Organic
formulas
11.4.7.1.1.4. Others
11.4.7.1.2. Enteral Nutrition
11.4.7.1.2.1. Standard
composition
11.4.7.1.2.2. Disease
specific composition
11.4.7.1.3. Parenteral nutrition
11.4.7.1.3.1. Amino
acids
11.4.7.1.3.2. Fats
11.4.7.1.3.3. Carbohydrates
11.4.7.1.3.4. Others
11.4.7.2. Benelux Union Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.4.7.2.1. Children
11.4.7.2.2. Adult
11.4.7.3. Benelux Union Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of Europe
11.4.8.1. Rest of Europe Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
11.4.8.1.1. Infant Nutrition
11.4.8.1.1.1. Milk
formulas
11.4.8.1.1.2. Soy
formulas
11.4.8.1.1.3. Organic
formulas
11.4.8.1.1.4. Others
11.4.8.1.2. Enteral Nutrition
11.4.8.1.2.1. Standard
composition
11.4.8.1.2.2. Disease
specific composition
11.4.8.1.3. Parenteral nutrition
11.4.8.1.3.1. Amino
acids
11.4.8.1.3.2. Fats
11.4.8.1.3.3. Carbohydrates
11.4.8.1.3.4. Others
11.4.8.2. Rest of Europe Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
11.4.8.2.1. Children
11.4.8.2.2. Adult
11.5. Key Segment for Channeling Investments
11.5.1. By Country
11.5.2. By Product
11.5.3. By Consumer
12. Asia Pacific Clinical Nutrition Market Analysis and
Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia Pacific Clinical Nutrition Market Revenue (US$ Mn)
12.2. Asia Pacific Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.2.1. Infant Nutrition
12.2.1.1. Milk formulas
12.2.1.2. Soy formulas
12.2.1.3. Organic formulas
12.2.1.4. Others
12.2.2. Enteral Nutrition
12.2.2.1. Standard composition
12.2.2.2. Disease specific composition
12.2.3. Parenteral nutrition
12.2.3.1. Amino acids
12.2.3.2. Fats
12.2.3.3. Carbohydrates
12.2.3.4. Others
12.3. Asia Pacific Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.3.1. Children
12.3.2. Adult
12.4. Asia Pacific Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.1. China
12.4.1.1. China Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.4.1.1.1. Infant Nutrition
12.4.1.1.1.1. Milk
formulas
12.4.1.1.1.2. Soy
formulas
12.4.1.1.1.3. Organic
formulas
12.4.1.1.1.4. Others
12.4.1.1.2. Enteral Nutrition
12.4.1.1.2.1. Standard
composition
12.4.1.1.2.2. Disease
specific composition
12.4.1.1.3. Parenteral nutrition
12.4.1.1.3.1. Amino
acids
12.4.1.1.3.2. Fats
12.4.1.1.3.3. Carbohydrates
12.4.1.1.3.4. Others
12.4.1.2. China Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.4.1.2.1. Children
12.4.1.2.2. Adult
12.4.2. Japan
12.4.2.1. Japan Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.4.2.1.1. Infant Nutrition
12.4.2.1.1.1. Milk
formulas
12.4.2.1.1.2. Soy
formulas
12.4.2.1.1.3. Organic
formulas
12.4.2.1.1.4. Others
12.4.2.1.2. Enteral Nutrition
12.4.2.1.2.1. Standard
composition
12.4.2.1.2.2. Disease
specific composition
12.4.2.1.3. Parenteral nutrition
12.4.2.1.3.1. Amino
acids
12.4.2.1.3.2. Fats
12.4.2.1.3.3. Carbohydrates
12.4.2.1.3.4. Others
12.4.2.2. Japan Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.4.2.2.1. Children
12.4.2.2.2. Adult
12.4.3. India
12.4.3.1. India Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.4.3.1.1. Infant Nutrition
12.4.3.1.1.1. Milk
formulas
12.4.3.1.1.2. Soy
formulas
12.4.3.1.1.3. Organic
formulas
12.4.3.1.1.4. Others
12.4.3.1.2. Enteral Nutrition
12.4.3.1.2.1. Standard
composition
12.4.3.1.2.2. Disease
specific composition
12.4.3.1.3. Parenteral nutrition
12.4.3.1.3.1. Amino
acids
12.4.3.1.3.2. Fats
12.4.3.1.3.3. Carbohydrates
12.4.3.1.3.4. Others
12.4.3.2. India Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.4.3.2.1. Children
12.4.3.2.2. Adult
12.4.4. New Zealand
12.4.4.1. New Zealand Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.4.4.1.1. Infant Nutrition
12.4.4.1.1.1. Milk
formulas
12.4.4.1.1.2. Soy
formulas
12.4.4.1.1.3. Organic
formulas
12.4.4.1.1.4. Others
12.4.4.1.2. Enteral Nutrition
12.4.4.1.2.1. Standard
composition
12.4.4.1.2.2. Disease
specific composition
12.4.4.1.3. Parenteral nutrition
12.4.4.1.3.1. Amino
acids
12.4.4.1.3.2. Fats
12.4.4.1.3.3. Carbohydrates
12.4.4.1.3.4. Others
12.4.4.2. New Zealand Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.4.4.2.1. Children
12.4.4.2.2. Adult
12.4.5. Australia
12.4.5.1. Australia Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.4.5.1.1. Infant Nutrition
12.4.5.1.1.1. Milk
formulas
12.4.5.1.1.2. Soy
formulas
12.4.5.1.1.3. Organic
formulas
12.4.5.1.1.4. Others
12.4.5.1.2. Enteral Nutrition
12.4.5.1.2.1. Standard
composition
12.4.5.1.2.2. Disease
specific composition
12.4.5.1.3. Parenteral nutrition
12.4.5.1.3.1. Amino
acids
12.4.5.1.3.2. Fats
12.4.5.1.3.3. Carbohydrates
12.4.5.1.3.4. Others
12.4.5.2. Australia Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.4.5.2.1. Children
12.4.5.2.2. Adult
12.4.6. South Korea
12.4.6.1. South Korea Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.4.6.1.1. Infant Nutrition
12.4.6.1.1.1. Milk
formulas
12.4.6.1.1.2. Soy
formulas
12.4.6.1.1.3. Organic
formulas
12.4.6.1.1.4. Others
12.4.6.1.2. Enteral Nutrition
12.4.6.1.2.1. Standard
composition
12.4.6.1.2.2. Disease
specific composition
12.4.6.1.3. Parenteral nutrition
12.4.6.1.3.1. Amino
acids
12.4.6.1.3.2. Fats
12.4.6.1.3.3. Carbohydrates
12.4.6.1.3.4. Others
12.4.6.2. South Korea Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.4.6.2.1. Children
12.4.6.2.2. Adult
12.4.7. Southeast Asia
12.4.7.1. Southeast Asia Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
12.4.7.1.1. Infant Nutrition
12.4.7.1.1.1. Milk
formulas
12.4.7.1.1.2. Soy
formulas
12.4.7.1.1.3. Organic
formulas
12.4.7.1.1.4. Others
12.4.7.1.2. Enteral Nutrition
12.4.7.1.2.1. Standard
composition
12.4.7.1.2.2. Disease
specific composition
12.4.7.1.3. Parenteral nutrition
12.4.7.1.3.1. Amino
acids
12.4.7.1.3.2. Fats
12.4.7.1.3.3. Carbohydrates
12.4.7.1.3.4. Others
12.4.7.2. Southeast Asia Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
12.4.7.2.1. Children
12.4.7.2.2. Adult
12.4.7.3. Southeast Asia Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest of Southeast Asia
12.4.8. Rest of Asia Pacific
12.4.8.1. Rest of Asia Pacific Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Product
12.4.8.1.1. Infant Nutrition
12.4.8.1.1.1. Milk
formulas
12.4.8.1.1.2. Soy
formulas
12.4.8.1.1.3. Organic
formulas
12.4.8.1.1.4. Others
12.4.8.1.2. Enteral Nutrition
12.4.8.1.2.1. Standard
composition
12.4.8.1.2.2. Disease
specific composition
12.4.8.1.3. Parenteral nutrition
12.4.8.1.3.1. Amino
acids
12.4.8.1.3.2. Fats
12.4.8.1.3.3. Carbohydrates
12.4.8.1.3.4. Others
12.4.8.2. Rest of Asia Pacific Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Consumer
12.4.8.2.1. Children
12.4.8.2.2. Adult
12.5. Key Segment for Channeling Investments
12.5.1. By Country
12.5.2. By Product
12.5.3. By Consumer
13. Middle East and Africa Clinical Nutrition Market Analysis and
Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Middle East and Africa Clinical Nutrition Market Revenue (US$
Mn)
13.2. Middle East and Africa Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Product
13.2.1. Infant Nutrition
13.2.1.1. Milk formulas
13.2.1.2. Soy formulas
13.2.1.3. Organic formulas
13.2.1.4. Others
13.2.2. Enteral Nutrition
13.2.2.1. Standard composition
13.2.2.2. Disease specific composition
13.2.3. Parenteral nutrition
13.2.3.1. Amino acids
13.2.3.2. Fats
13.2.3.3. Carbohydrates
13.2.3.4. Others
13.3. Middle East and Africa Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Consumer
13.3.1. Children
13.3.2. Adult
13.4. Middle East and Africa Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Country
13.4.1. Saudi Arabia
13.4.1.1. Saudi Arabia Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
13.4.1.1.1. Infant Nutrition
13.4.1.1.1.1. Milk
formulas
13.4.1.1.1.2. Soy
formulas
13.4.1.1.1.3. Organic
formulas
13.4.1.1.1.4. Others
13.4.1.1.2. Enteral Nutrition
13.4.1.1.2.1. Standard
composition
13.4.1.1.2.2. Disease
specific composition
13.4.1.1.3. Parenteral nutrition
13.4.1.1.3.1. Amino
acids
13.4.1.1.3.2. Fats
13.4.1.1.3.3. Carbohydrates
13.4.1.1.3.4. Others
13.4.1.2. Saudi Arabia Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
13.4.1.2.1. Children
13.4.1.2.2. Adult
13.4.2. UAE
13.4.2.1. UAE Clinical Nutrition Market Revenue (US$ Mn) and Forecasts,
By Product
13.4.2.1.1. Infant Nutrition
13.4.2.1.1.1. Milk
formulas
13.4.2.1.1.2. Soy
formulas
13.4.2.1.1.3. Organic
formulas
13.4.2.1.1.4. Others
13.4.2.1.2. Enteral Nutrition
13.4.2.1.2.1. Standard
composition
13.4.2.1.2.2. Disease
specific composition
13.4.2.1.3. Parenteral nutrition
13.4.2.1.3.1. Amino
acids
13.4.2.1.3.2. Fats
13.4.2.1.3.3. Carbohydrates
13.4.2.1.3.4. Others
13.4.2.2. UAE Clinical Nutrition Market Revenue (US$ Mn) and Forecasts,
By Consumer
13.4.2.2.1. Children
13.4.2.2.2. Adult
13.4.3. Egypt
13.4.3.1. Egypt Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
13.4.3.1.1. Infant Nutrition
13.4.3.1.1.1. Milk
formulas
13.4.3.1.1.2. Soy
formulas
13.4.3.1.1.3. Organic
formulas
13.4.3.1.1.4. Others
13.4.3.1.2. Enteral Nutrition
13.4.3.1.2.1. Standard
composition
13.4.3.1.2.2. Disease
specific composition
13.4.3.1.3. Parenteral nutrition
13.4.3.1.3.1. Amino
acids
13.4.3.1.3.2. Fats
13.4.3.1.3.3. Carbohydrates
13.4.3.1.3.4. Others
13.4.3.2. Egypt Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
13.4.3.2.1. Children
13.4.3.2.2. Adult
13.4.4. Kuwait
13.4.4.1. Kuwait Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
13.4.4.1.1. Infant Nutrition
13.4.4.1.1.1. Milk
formulas
13.4.4.1.1.2. Soy
formulas
13.4.4.1.1.3. Organic
formulas
13.4.4.1.1.4. Others
13.4.4.1.2. Enteral Nutrition
13.4.4.1.2.1. Standard
composition
13.4.4.1.2.2. Disease
specific composition
13.4.4.1.3. Parenteral nutrition
13.4.4.1.3.1. Amino
acids
13.4.4.1.3.2. Fats
13.4.4.1.3.3. Carbohydrates
13.4.4.1.3.4. Others
13.4.4.2. Kuwait Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
13.4.4.2.1. Children
13.4.4.2.2. Adult
13.4.5. South Africa
13.4.5.1. South Africa Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
13.4.5.1.1. Infant Nutrition
13.4.5.1.1.1. Milk
formulas
13.4.5.1.1.2. Soy
formulas
13.4.5.1.1.3. Organic
formulas
13.4.5.1.1.4. Others
13.4.5.1.2. Enteral Nutrition
13.4.5.1.2.1. Standard
composition
13.4.5.1.2.2. Disease
specific composition
13.4.5.1.3. Parenteral nutrition
13.4.5.1.3.1. Amino
acids
13.4.5.1.3.2. Fats
13.4.5.1.3.3. Carbohydrates
13.4.5.1.3.4. Others
13.4.5.2. South Africa Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
13.4.5.2.1. Children
13.4.5.2.2. Adult
13.4.6. Rest of Middle East & Africa
13.4.6.1. Rest of Middle East & Africa Clinical Nutrition Market
Revenue (US$ Mn) and Forecasts, By Product
13.4.6.1.1. Infant Nutrition
13.4.6.1.1.1. Milk
formulas
13.4.6.1.1.2. Soy
formulas
13.4.6.1.1.3. Organic
formulas
13.4.6.1.1.4. Others
13.4.6.1.2. Enteral Nutrition
13.4.6.1.2.1. Standard
composition
13.4.6.1.2.2. Disease
specific composition
13.4.6.1.3. Parenteral nutrition
13.4.6.1.3.1. Amino
acids
13.4.6.1.3.2. Fats
13.4.6.1.3.3. Carbohydrates
13.4.6.1.3.4. Others
13.4.6.2. Rest of Middle East & Africa Clinical Nutrition Market
Revenue (US$ Mn) and Forecasts, By Consumer
13.4.6.2.1. Children
13.4.6.2.2. Adult
13.5. Key Segment for Channeling Investments
13.5.1. By Country
13.5.2. By Product
13.5.3. By Consumer
14. Latin America Clinical Nutrition Market Analysis and
Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin America Clinical Nutrition Market Revenue (US$ Mn)
14.2. Latin America Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
14.2.1. Infant Nutrition
14.2.1.1. Milk formulas
14.2.1.2. Soy formulas
14.2.1.3. Organic formulas
14.2.1.4. Others
14.2.2. Enteral Nutrition
14.2.2.1. Standard composition
14.2.2.2. Disease specific composition
14.2.3. Parenteral nutrition
14.2.3.1. Amino acids
14.2.3.2. Fats
14.2.3.3. Carbohydrates
14.2.3.4. Others
14.3. Latin America Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
14.3.1. Children
14.3.2. Adult
14.4. Latin America Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Country
14.4.1. Brazil
14.4.1.1. Brazil Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
14.4.1.1.1. Infant Nutrition
14.4.1.1.1.1. Milk
formulas
14.4.1.1.1.2. Soy
formulas
14.4.1.1.1.3. Organic
formulas
14.4.1.1.1.4. Others
14.4.1.1.2. Enteral Nutrition
14.4.1.1.2.1. Standard
composition
14.4.1.1.2.2. Disease
specific composition
14.4.1.1.3. Parenteral nutrition
14.4.1.1.3.1. Amino
acids
14.4.1.1.3.2. Fats
14.4.1.1.3.3. Carbohydrates
14.4.1.1.3.4. Others
14.4.1.2. Brazil Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
14.4.1.2.1. Children
14.4.1.2.2. Adult
14.4.2. Argentina
14.4.2.1. Argentina Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Product
14.4.2.1.1. Infant Nutrition
14.4.2.1.1.1. Milk
formulas
14.4.2.1.1.2. Soy
formulas
14.4.2.1.1.3. Organic
formulas
14.4.2.1.1.4. Others
14.4.2.1.2. Enteral Nutrition
14.4.2.1.2.1. Standard
composition
14.4.2.1.2.2. Disease
specific composition
14.4.2.1.3. Parenteral nutrition
14.4.2.1.3.1. Amino
acids
14.4.2.1.3.2. Fats
14.4.2.1.3.3. Carbohydrates
14.4.2.1.3.4. Others
14.4.2.2. Argentina Clinical Nutrition Market Revenue (US$ Mn) and
Forecasts, By Consumer
14.4.2.2.1. Children
14.4.2.2.2. Adult
14.4.3. Rest of Latin America
14.4.3.1. Rest of Latin America Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Product
14.4.3.1.1. Infant Nutrition
14.4.3.1.1.1. Milk
formulas
14.4.3.1.1.2. Soy
formulas
14.4.3.1.1.3. Organic
formulas
14.4.3.1.1.4. Others
14.4.3.1.2. Enteral Nutrition
14.4.3.1.2.1. Standard
composition
14.4.3.1.2.2. Disease
specific composition
14.4.3.1.3. Parenteral nutrition
14.4.3.1.3.1. Amino
acids
14.4.3.1.3.2. Fats
14.4.3.1.3.3. Carbohydrates
14.4.3.1.3.4. Others
14.4.3.2. Rest of Latin America Clinical Nutrition Market Revenue (US$
Mn) and Forecasts, By Consumer
14.4.3.2.1. Children
14.4.3.2.2. Adult
14.5. Key Segment for Channeling Investments
14.5.1. By Country
14.5.2. By Product
14.5.3. By Consumer
15. Competitive Benchmarking
15.1. Brand Benchmarking
15.2. Market Share Analysis, 2018
15.3. Global Presence and Growth Strategies
15.3.1. Mergers and Acquisitions
15.3.2. Product Launches
15.3.3. Investments Trends
15.3.4. R&D Initiatives
16. Player Profiles
16.1. Fresenius Kabi
16.1.1. Company Details
16.1.2. Company Overview
16.1.3. Product Offerings
16.1.4. Key Developments
16.1.5. Financial Analysis
16.1.6. SWOT Analysis
16.1.7. Business Strategies
16.2. Abbott Laboratories
16.2.1. Company Details
16.2.2. Company Overview
16.2.3. Product Offerings
16.2.4. Key Developments
16.2.5. Financial Analysis
16.2.6. SWOT Analysis
16.2.7. Business Strategies
16.3. B.Braun
16.3.1. Company Details
16.3.2. Company Overview
16.3.3. Product Offerings
16.3.4. Key Developments
16.3.5. Financial Analysis
16.3.6. SWOT Analysis
16.3.7. Business Strategies
16.4. Baxter
16.4.1. Company Details
16.4.2. Company Overview
16.4.3. Product Offerings
16.4.4. Key Developments
16.4.5. Financial Analysis
16.4.6. SWOT Analysis
16.4.7. Business Strategies
16.5. Danone
16.5.1. Company Details
16.5.2. Company Overview
16.5.3. Product Offerings
16.5.4. Key Developments
16.5.5. Financial Analysis
16.5.6. SWOT Analysis
16.5.7. Business Strategies
16.6. Mead Johnson
16.6.1. Company Details
16.6.2. Company Overview
16.6.3. Product Offerings
16.6.4. Key Developments
16.6.5. Financial Analysis
16.6.6. SWOT Analysis
16.6.7. Business Strategies
16.7. Nestle
16.7.1. Company Details
16.7.2. Company Overview
16.7.3. Product Offerings
16.7.4. Key Developments
16.7.5. Financial Analysis
16.7.6. SWOT Analysis
16.7.7. Business Strategies
16.8. Perrigo
16.8.1. Company Details
16.8.2. Company Overview
16.8.3. Product Offerings
16.8.4. Key Developments
16.8.5. Financial Analysis
16.8.6. SWOT Analysis
16.8.7. Business Strategies
16.9. Other Market Participants
17. Key Findings
Note: This ToC is tentative and can
be changed according to the research study conducted during the course of
report completion.
**Exclusive for Multi-User and
Enterprise Use
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.